Gilead Sciences spent some 5.9 billion U.S. dollars on research and development in 2024. The statistic illustrates Gilead Sciences' spending on research and development from 2008 to 2024. In 2024, Gilead Sciences shot to the public limelight over its drug remdesivir (brand name Veklury), which was trialed and later approved as a drug against COVID-19.
Research and development spending of Gilead Sciences from 2008 to 2024
(in million U.S. dollars)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
The statistic is available in another language. Switch language.
Print the statistic including description and metadata.
Chart type
Research and development spending of Gilead Sciences from 2008 to 2024
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
Gilead Sciences, & U.S. Securities and Exchange Commission. (February 26, 2025). Research and development spending of Gilead Sciences from 2008 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 26, 2025, from https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/
Gilead Sciences, und U.S. Securities and Exchange Commission. "Research and development spending of Gilead Sciences from 2008 to 2024 (in million U.S. dollars)." Chart. February 26, 2025. Statista. Accessed April 26, 2025. https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/
Gilead Sciences, U.S. Securities and Exchange Commission. (2025). Research and development spending of Gilead Sciences from 2008 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 26, 2025. https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/
Gilead Sciences, and U.S. Securities and Exchange Commission. "Research and Development Spending of Gilead Sciences from 2008 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 26 Feb 2025, https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/
Gilead Sciences & U.S. Securities and Exchange Commission, Research and development spending of Gilead Sciences from 2008 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/ (last visited April 26, 2025)
Research and development spending of Gilead Sciences from 2008 to 2024 (in million U.S. dollars) [Graph], Gilead Sciences, & U.S. Securities and Exchange Commission, February 26, 2025. [Online]. Available: https://www.statista.com/statistics/274510/spending-on-research-and-development-by-gilead-sciences/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
